Nov 16 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS PRESENTS NEW OPREGEN DATA FOR
DRY AMD
WITH GA AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
* LINEAGE CELL THERAPEUTICS INC - IMPROVED VISUAL ACUITY
CONTINUES
TO BE OBSERVED IN COHORT 4 PATIENTS
* LINEAGE CELL THERAPEUTICS INC - FIRST KNOWN CLINICAL
REPORT OF
RETINAL TISSUE REGENERATION PERSISTED TO 23 MONTHS WITH FURTHER
IMPROVEMENT IN VISUAL ACUITY
Source text for Eikon: ID:nBw8rkXTpa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))